Abstract
In cases with breast cancer, probably benign lesions can also be seen in the other areas of the breast. It is known that neoadjuvant chemotherapy causes morphological changes in the normal breast tissue and the benign lesions, in addition to effects on malignant mass. In cases with complete response with neoadjuvant chemotherapy, probably benign lesions without tissue diagnosis cause a dilemma in the breast conserving surgery plan, when they shrink or disappear at the end of the treatment. We aimed to demonstrate the effects of neoadjuvant chemotherapy in cases with probably benign breast lesions via dynamic contrast enhanced breast MRI.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
